Alzheimer's Disease Trial, Recruiting (NCT05929703)

Alzheimer's Disease Trial, Recruiting NCT05929703 Sponsor: University of Michigan Condition: Alzheimer's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05929703 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Alzheimers Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are willing to give your agreement to take part in the study
You are 70 years of age or older
You are expected to stay in the hospital for at least 72 hours
You have a family member or care partner who can be present with you in the hospital
You have at least one risk factor for delirium, such as memory problems, difficulty with daily tasks, dehydration, or problems with your vision or hearing
You are able to complete a basic memory and thinking test at the start of the study

Who may not be able to join:

You are already showing signs of delirium when you arrive at the hospital
You are unable to speak or communicate verbally, for example if you are unconscious or on a breathing machine
You are not able to fully take part in the study activities, for example due to a terminal illness or advanced dementia
There are concerns about the safety of hospital staff around you, for example due to aggressive or violent behaviour
You are having heart surgery or brain surgery, as these can cause their own risk of delirium (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sharon K Inouye, MD, Hebrew SeniorLife

Phone: 617-971-5390

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05929703

Sponsor: University of Michigan

Phase: Not Applicable

Status: Recruiting

Condition: Alzheimer's Disease

Trial contact: 617-971-5390

More information: https://clinicaltrials.gov/study/NCT05929703

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are willing to give your agreement to take part in the study
You are 70 years of age or older
You are expected to stay in the hospital for at least 72 hours
You have a family member or care partner who can be present with you in the hospital
You have at least one risk factor for delirium, such as memory problems, difficulty with daily tasks, dehydration, or problems with your vision or hearing
You are able to complete a basic memory and thinking test at the start of the study

Who may not be able to join:

You are already showing signs of delirium when you arrive at the hospital
You are unable to speak or communicate verbally, for example if you are unconscious or on a breathing machine
You are not able to fully take part in the study activities, for example due to a terminal illness or advanced dementia
There are concerns about the safety of hospital staff around you, for example due to aggressive or violent behaviour
You are having heart surgery or brain surgery, as these can cause their own risk of delirium (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Michigan

Registry

ClinicalTrials.gov

Start date

4 December 2023

Est. completion

1 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Delirium Incidence; Delirium Severity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov